High-intensity interval training (HIIT) and a longer but more moderate exercise regimen seem to be of similar benefit to…
Articles by Lindsey Shapiro, PhD
Geographical proximity to neurologists and multiple sclerosis (MS) speciality care centers is lower for people living in rural regions…
A diet low in wheat was linked to reductions in circulating inflammatory immune cells and improvements in pain-related life quality…
A smartphone application called Floodlight Open may help in tracking areas of function in people with multiple sclerosis (MS),…
Junctions between nerve cells and certain cells called oligodendrocyte precursor cells, or OPCs, in the brain and spinal cord may…
Women with a history of depression around the time they get pregnant are at increased risk of developing autoimmune diseases…
Daily treatment with CNM-Au8 led to sustained improvements in vision and cognition for people with relapsing-remitting multiple sclerosis (RRMS),…
The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial to test Kyverna Therapeutics‘ cell-based…
Immune responses against an ancient viral protein called pHERV-W that’s encoded in the human genome are higher in relapsing-remitting…
The presence of damaged myelin — the fatty, protective substance surrounding nerve cells that’s lost in multiple sclerosis…
About three-quarters of multiple sclerosis (MS) patients given an under-the-skin formulation of cladribine had no disease activity or didn’t…
Women who smoked during pregnancy, and their offspring, showed a significantly higher risk of developing multiple sclerosis (MS) in…
The Swank and Wahls diets — two dietary strategies often adopted by people with multiple sclerosis (MS) — were…
Advanced Innovative Partners (AIP) has agreed to assist GlobeStar Therapeutics Corporation and SMI Healthcare in designing…
A stem cell transplant was found to be better than Lemtrada (alemtuzumab) for lowering disease activity and slowing disability…
A scoring system that accounts for relapses and MRI activity in multiple sclerosis (MS) patients during their first year on…
The most common real-world side effects linked to dalfampridine — sold as Ampyra and with generics available — are…
A patient’s ability to cope with and recover from adversity — called psychological resilience — was found to impact the…
Experiencing certain stressors during childhood may predict the future presence and severity of fatigue, pain, and psychiatric conditions associated with…
In a surprise discovery, researchers found that deleting a protein called integrin alpha-3 blocked harmful immune cells from accessing the…
The risk of converting to secondary-progressive multiple sclerosis (SPMS) has declined in recent years for patients who have an…
Multiple sclerosis (MS) patients had significantly more sickness-related work absences in the years leading up to their disease onset…
Treatment with tolebrutinib for up to nearly three years was tied to low relapse rates, stable disability, and few…
Obese people with multiple sclerosis (MS) had faster disability accumulation, greater cognitive declines, and worse quality of life in…
People with relapsing-remitting multiple sclerosis (RRMS) who had an early start on high-efficacy disease-modifying therapies (DMTs) experience slower…
A cognitive behavioral therapy (CBT) program delivered virtually — using self-paced remote modules — significantly eased depressive symptoms and improved…
Nearly three-quarters of people with relapsing-remitting multiple sclerosis (RRMS) showed no signs of disease activity five years after receiving…
Nearly 1 in 5 people on Medicare — a U.S. federal insurance program for people ages 65 and older —…
Researchers at the Kessler Foundation have received $725,499 from the National Multiple Sclerosis Society to study how to…
Greater self-reported physical disability within the first years of being diagnosed with relapsing-remitting multiple sclerosis (MS) is associated with…